Bayer Collaborates with UC Davis Venture Catalyst to Support Regional Innovation and Entrepreneurship

Bayer Collaborates with UC Davis Venture Catalyst to Support Regional Innovation and Entrepreneurship

Bayer Collaborates with UC Davis Venture Catalyst to Support Regional Innovation and Entrepreneurship

The University of California, Davis announced today a strategic collaboration agreement with Bayer Crop Science to foster innovation and economic development in the Sacramento region by providing dedicated facility support for university-affiliated startups — particularly those in the areas of agriculture and food-related technologies. 

Located within Bayer’s West Sacramento Innovation Hub for Crop Science, the 3,000 square-foot CoLaborator is designed to house and foster innovative new ventures to transform modern agriculture.  It consists of a flexible floor plan that has the capacity for eight to ten researchers and provides basic equipment for agtech startups to quickly begin putting their ideas to the test.  San Francisco-bred Biome Makers, Inc., a rising startup in the field of microbiomes, is the CoLaborator’s first tenant and chose West Sacramento over the Bay Area as their headquarters

“Working with Bayer provides our campus entrepreneurs with another tremendous resource and further strengthens the growing regional innovation ecosystem,” said Dushyant Pathak, associate vice chancellor of Research and executive director of Venture Catalyst at UC Davis. “The value of this effort extends much further than addressing the need for appropriate facilities, it creates an opportunity for entrepreneurs to engage with other experts in and outside their field and build relationships critical for their success.”

As part of the agreement, Bayer joins the university’s Distributed Research Incubation and Venture Engine (DRIVETM) network of startup incubators. The DRIVE network is part of a platform of resources offered by UC Davis Venture Catalyst to support the successful translation of research and new technologies emerging from the university into new commercial ventures. Venture Catalyst is part of the Technology Management and Corporate Relations division of the UC Davis Office of Research.

“We are thrilled to be working with the University of California, Davis to help grow new ventures with the possibility to transform modern agriculture,” said Jon Margolis, Head of Research and Technologies BLX.  “While we at Bayer are proud of the advances in our own laboratories, we recognize that the challenges today’s growers face will require an open innovation strategy that taps into the larger scientific community.”

About UC Davis

UC Davis is a global community of individuals united to better humanity and our natural world while seeking solutions to some of our most pressing challenges. Located near the California state capital, UC Davis has more than 35,000 students, an annual research budget of over $780 million and a comprehensive health system. The university offers 102 undergraduate majors and 99 graduate programs through four colleges and six professional schools.

About Venture Catalyst

Venture Catalyst is one of three units within the Technology Management and Corporate Relations division of the UC Davis Office of Research. Venture Catalyst furthers the university’s educational, research and public mission by supporting UC Davis students, faculty and researchers in translating science, engineering and innovative research, through well-resourced startups, into societal impact.

About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.

 

Follow Us
Posted in News.